Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells

Citation
Cr. Hauck et al., Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells, CANCER RES, 61(19), 2001, pp. 7079-7090
Citations number
80
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
61
Issue
19
Year of publication
2001
Pages
7079 - 7090
Database
ISI
SICI code
0008-5472(20011001)61:19<7079:IOFAKE>2.0.ZU;2-Q
Abstract
Elevated focal adhesion kinase (FAK) expression in human tumor cells has be en correlated with an increased cell invasion potential. In cell culture, s tudies with FAK-null fibroblasts have shown that FAK function is required f or cell migration. To determine the role of elevated FAK expression in faci litating epidermal growth factor (EGF)-stimulated human adenocarcinoma (A54 9) cell motility, antisense oligonucleotides were used to reduce FAK protei n expression >75%. Treatment of A549 cells with FAK antisense (ISIS 15421) but not a mismatched control (ISIS 17636) oligonucleotide resulted in reduc ed EGF-stimulated p130(Cas)-Src complex formation, e-Jun NH2-terminal kinas e (JNK) activation, directed cell motility, and serum-stimulated cell invas ion through Matrigel. Because residual FAK protein in ISIS 15421-treated A5 49 cells was highly phosphorylated at the Tyr-397/Src homology (SH)2 bindin g site, expression of the FAK COOH-terminal domain (FRNK) was also used as an inhibitor of FAK function. Adenoviral-mediated infection and expression of FRNK promoted FAK dephosphorylation at Tyr-397, resulted in reduced EGF- stimulated JNK as well as extracellular-regulated kinase 2 (ERK2) kinase ac tivation, inhibited matrix metalloproteinase-9 (MMP-9) secretion, and poten tly blocked both random and EGF-stimulated A549 cell motility. Equivalent e xpression of a FRNK (S-1034) point-mutant that did not promote FAK dephosph orylation also did not affect EGF-stimulated signaling or cell motility. Do se-dependent reduction in EGF-stimulated A549 motility was observed with th e PD98059 MEK1 inhibitor and the batimastat (BB-94) inhibitor of MMP activi ty, but not with the SB203580 inhibitor of P38 kinase. Finally, comparisons between normal, FAK-null, and FAK-reconstituted fibroblasts revealed that FAK enhanced EGF-stimulated JNK and ERK2 kinase activation that was require d for cell motility. These data indicate that FAK functions as an important signaling platform to coordinate EGF-stimulated cell migration in human tu mor cells and support a role for inhibitors of FAK expression or activity i n the control of neoplastic cell invasion.